Stay updated on Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial

Sign up to get notified when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Website revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T02:20:32.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; deleted a government funding status notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:00:23.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the page revision from v3.4.0 to v3.4.1. These changes do not affect study details or outcomes.
    Difference
    0.3%
    Check dated 2026-02-04T07:56:12.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option to the page. Updated metadata/labels: capitalization of 'Last Update Submitted that Met QC Criteria', the footer now displays 'No FEAR Act Data', and the site revision is updated to 'v3.4.0'.
    Difference
    0.2%
    Check dated 2026-01-28T05:49:50.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page revision changed from v3.3.3 to v3.3.4, indicating a small metadata update.
    Difference
    0.0%
    Check dated 2026-01-14T03:23:35.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a Locations section listing study sites by state (Arizona, California, Colorado, Florida, Illinois, Iowa, Kentucky, Massachusetts, Missouri, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oregon, Pennsylvania, Texas, Washington, West Virginia) and updated to Revision: v3.3.3; removed the previous separate Arizona Locations, California Locations, etc.
    Difference
    2%
    Check dated 2025-12-23T20:48:13.000Z thumbnail image

Stay in the know with updates to Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.